Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-TNF mode of action?

A. Finckh; D. Courvoisier; J.-E. Gottenberg; X. Mariette; J. Morel; S. A. Bergstra; V. Hernandez; C. Codreanu; T. K.  Kvien; M. J. Santos; K. Pavelka; Merete Lund Hetland; K. Chatzidionysiou; J. Askling; C. Turesson; C. Gabay; R. Van Vollenhoven

Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-TNF mode of action?

A. Finckh, D. Courvoisier, J.-E. Gottenberg, X. Mariette, J. Morel, S. A. Bergstra, V. Hernandez, C. Codreanu, T. K. Kvien, M. J. Santos, K. Pavelka, Merete Lund Hetland, K. Chatzidionysiou, J. Askling, C. Turesson, C. Gabay, R. Van Vollenhoven

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Originalsprog	Engelsk
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	76
Udgave nummer	Suppl 2
Sider (fra-til)	567
Antal sider	1
ISSN	0003-4967
Status	Udgivet - 2017

Citationsformater

Finckh, A., Courvoisier, D., Gottenberg, J.-E., Mariette, X., Morel, J., Bergstra, S. A., Hernandez, V., Codreanu, C., Kvien, T. K., Santos, M. J., Pavelka, K., Hetland, M. L., Chatzidionysiou, K., Askling, J., Turesson, C., Gabay, C., & Van Vollenhoven, R. (2017). Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-TNF mode of action? Annals of the Rheumatic Diseases, 76(Suppl 2), 567.

Finckh, A, Courvoisier, D, Gottenberg, J-E, Mariette, X, Morel, J, Bergstra, SA, Hernandez, V, Codreanu, C, Kvien, TK, Santos, MJ, Pavelka, K, Hetland, ML, Chatzidionysiou, K, Askling, J, Turesson, C, Gabay, C & Van Vollenhoven, R 2017, 'Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-TNF mode of action?', Annals of the Rheumatic Diseases, bind 76, nr. Suppl 2, s. 567.

@article{7ed0d39c98724e528f1fc23fd8a96476,

title = "Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-TNF mode of action?",

author = "A. Finckh and D. Courvoisier and J.-E. Gottenberg and X. Mariette and J. Morel and Bergstra, {S. A.} and V. Hernandez and C. Codreanu and Kvien, {T. K.} and Santos, {M. J.} and K. Pavelka and Hetland, {Merete Lund} and K. Chatzidionysiou and J. Askling and C. Turesson and C. Gabay and {Van Vollenhoven}, R.",

note = "COPECARE",

year = "2017",

language = "English",

volume = "76",

pages = "567",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",